Effect of glucoprivation on serotonin neurotoxicity induced by substituted amphetamines

Journal of Pharmacology and Experimental Therapeutics

Volumn 303, Issue 2, 2002, Pages 831-839

  Yuan, Jie ^a   Cord, Branden J ^a   McCann, Una D ^a   Callahan, Brian T ^a   Ricaurte, George A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; AMPHETAMINE DERIVATIVE; DEOXYGLUCOSE; FENFLURAMINE; SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL MODEL; ARTICLE; BRAIN; BRAIN PROTECTION; CELL METABOLISM; CONTROLLED STUDY; CORE TEMPERATURE; DRUG MECHANISM; ENERGY METABOLISM; GLUCOSE TRANSPORT; GLYCOGENOLYSIS; HYPOTHERMIA; METABOLITE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

AMPHETAMINES; ANIMALS; ANTIMETABOLITES; BIOGENIC MONOAMINES; BODY TEMPERATURE; CARRIER PROTEINS; DEOXYGLUCOSE; ENERGY METABOLISM; FENFLURAMINE; GLUCOSE; HYDROXYINDOLEACETIC ACID; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NERVE DEGENERATION; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 0036827718     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.041277     Document Type: Article

References (50)

1. Albers DS and Sonsalla PK (1995) Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: Pharmacological profile of protective and nonprotective agents. J Pharmacol Exp Ther 275:1104-1114.
2. Albers DS, Zeevalk GD, and Sonsalla PK (1996) Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP. Brain Res 718:217-220.
3. Ali SF, Newport GD, and Slikker W Jr (1996) Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents. Ann N Y Acad Sci 801:187-198.
4. Appel NM, Mitchell WM, Contrera JF, and De Souza EB (1990) Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: Assessment using quantitative autoradiography. Synapse 6:33-44.
5. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W Jr, and Holson RR (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268:1571.
6. Bowyer JF, Tank AW, Newport GD, Slikker W Jr, Ali SF, and Holson RR (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 260:817-824.
7. Breier A, Crane AM, Kennedy C, and Sokoloff L (1993) The effects of pharmacologic doses of 2-deoxy-D-glucose on local cerebral blood flow in the awake, unrestrained rat. Brain Res 618:277-282.
8. Burrows KB, Nixdorf WL, and Yamamoto BK (2000) Central administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines. J Pharmacol Exp Ther 292:853-860.
9. Callahan BT, Yuan J, Stover G, Hatzidimitriou G, and Ricaurte GA (1998) Effects of 2-deoxy-D-Glucose on methamphetamine-induced dopamine and serotonin neurotoxicity. J Neurochem 70:190-197.
10. Chan P, DiMonte DA, Luo JJ, DeLanney LE, Irwin I, and Langston JW (1994) Rapid ATP loss caused by methamphetamine in the mouse striatum: Relationship between energy impairment and dopaminergic neurotoxicity. J Neurochem 62:2484-2487.
11. Colado MI, Granados R, O'Shea E, Esteban B, and Green AR (1998) Role of hyperthermia in the protective action of clomethiazole against MDMA ("ecstasy")-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR. Br J Pharm 124:479-484.
12. Darvesh AS, Shankaran M, and Gudelsky GA (2002) 3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain. J Pharmacol Exp Ther 301:138-144.
13. Farfel GM and Seiden LS (1995) Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, pchloroamphetamine, fenfluramine, dizocilpine, and dextrorphan. J Pharmacol Exp Ther 272:868-875.
14. Fuller RW (1985) Persistent effects of amphetamine, p-chloroamphetamine and related compounds on central dopamine and serotonin neurons in rodents. Psychopharmacol Bull 21:528-532.
15. Fuller RW and Hemrick-Luecke S (1980) Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats. Science (Wash DC) 209:305-307.
16. Fuller RW and Hemrick-Luecke SK (1982) Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine. Neuropharmacology 21:433-438.
17. Fumagalli F, Gainetdinov RR, Valenzano KJ, and Caron MG (1998) Role of dopamine transporter in methamphetamine-induced neurotoxicity: Evidence from mice lacking the transporter. J Neurosci 18:4861.
18. Gibb JW, Hanson GR, and Johnson M (1994) Neurochemical mechanisms of toxicity, in Amphetamine and its Analogs: Neuropsychopharmacol, Toxicology and Abuse (Cho A and Segal D eds) pp 269-289, Academic Press, New York.
19. Harvey JA and McMaster SE (1977) Fenfluramine: Cumulative neurotoxicity after chronic treatment with low dosages in the rat. Commun Psychopharmacol 1:3-17.
20. Hervias I, Lasheras B, and Aguirre N (2000) 2-Deoxy-D-glucose prevents and nicotinamide potentiates 3,4-methylenedioxymethamphetamine-indueed serotonin neurotoxicity. J Neurochem 75:982-990.
21. Hotchkiss AJ and Gibb JW (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 214:257-262.
22. Huang NK, Wan FJ, Tseng CJ, and Tung CS (1997) Nicotinamide attenuates methamphetamine-induced striatal dopamine depletion in rats. Neuro Report 8:1883-1885.
23. Kogan FJ, Nichols WK, and Gibb JW (1976) Influence of methamphetamine on nigral and striatal tryosine hydroxylase activity and on striatal dopamine levels. Eur J Pharmacol 36:363-371.
24. Lee J, Bruce-Keller AJ, Kruman Y, Chan SL, and Mattson MP (1999) 2-Deoxy-D-glucose protects hippocampal neurons against excitotoxic and oxidative injury: Evidence for the involvement of stress proteins. J Neurosci Res 57:48-61.
25. Lew R, Malberg JE, Ricaurte GA, and Seiden LS (1997) Evidence for and mechanism of action of neurotoxicity of amphetamine related compounds, in Highly Selective Neurotoxins: Basic and Clinical Applications (Kostrzewa RM ed) pp 235-268, Humana Press, Inc., Totowa, NJ.
26. Malberg JE and Seiden LS (1997) Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles. Brain Res 765:101-107.
27. Marek GJ, Vosmer G, and Seiden LS (1990) Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons. Brain Res 513:274-279.
28. McCann UD, Hatzidimitriou G, Ridenour A, Fisher C, Yuan J, Katz J, and Ricaurte GA (1994) Dexfenfluramine and serotonin neurotoxicity: Further preclinical evidence that clinical caution is indicated. J Pharmacol Exp Ther 269:792-798.
29. Miller KW, Freeman JJ, Dingell JV, and Sulser F (1970) On the mechanism of amphetamine potentiation by iprindole. Experientia 26:863-864.
30. Nixdorf WL, Burrows KB, Gudelsky GA, and Yamamoto BK (2001) Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate. J Neurochem 77:647-654.
31. O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, and Molliver ME (1988) Methylenedioxy-amphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: Immunocytochemical evidence for neurotoxicity. J Neurosci 8:2788-8803.
32. Ricaurte GA, Bryan G, Strauss L, Seiden LS, and Schuster CR (1985) Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science (Wash DC) 229:986-988.
33. Ricaurte GA, Guillery RW, Seiden LS, and Schuster CR (1984) Nerve terminal degeneration after a single injection of d-amphetamine in iprindole-treated rats: Relation to selective long-lasting dopamine depletion. Brain Res 291:378-382.
34. Ricaurte GA, Schuster CR, and Seiden LS (1980) Long-term effects of repeated methyl-amphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study. Brain Res 193:153-163.
35. Sanders-Bush E, Bushing JA, and Sulser F (1972) Long-term effects of pchloroamphetamine on tryptophan hydroxylase activity and on the levels of 5-hydroxytryptamine and 5-hydroxyindole acetic acid in brain. Eur J Pharmacol 20:385-388.
36. Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine methylenedioxymeth-amphetamine. J Pharmacol Exp Ther 240:1-7.
37. Schneider JE, Goldman MD, Leo NA, and Rosen ME (1997) Central vs. peripheral metabolic control of estrous cycles in Syrian hamsters. II. Glucoprivation. Am J Physiol 272:R406-R412.
38. Schuster CR, Lewis M, and Seiden LS (1986) Fenfluramine: Neurotoxicity. Psychopharmacol Bull 22:148-151.
39. Seiden LS, Fischman MW, and Schuster CR (1976) Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend 1:215-219.
40. Shiraishi T and Mager M (1980) 2-Deoxy-D-glucose-induced hypothermia: thermoregulatory pathways in rat. Am J Physiol 239:R270-R276.
41. Stephans SE, Whittingham TS, Douglas AJ, Lust WD, and Yamamoto BK (1998) Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum. J Neurochem 71:613-621.
42. Steranka LR (1982) Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: Time course and time-dependent interactions with amfonelic acid. Brain Res 234:123-136.
43. Steranka LR and Sanders-Bush E (1980) Long-term effects of continuous exposure to amphetamine on brain dopamine concentration and synaptosomal uptake in mice. Eur J Pharmacol 65:439.
44. Stewart CW, Bowyer JF, and Slikker W Jr (1997) Elevated environmental temperatures can induce hyperthermia during d-fenfluramine exposure and enhance 5-hydroxytryptamine (5-HT) depletion in the brain. J Pharmacol Exp Ther 283:1144-1150.
45. Stone DM, Stahl DC, Hanson GR, and Gibb JW (1986) The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur J Pharmacol 128:41-48.
46. Takahashi A, Ishimaru H, Ikarashi Y, Kishi E, and Maruyama Y (1997) Hypothalamic cholinergic activity and 2-deoxyglucose-induced hyperglycemia. Brain Res Bull 43:65-68.
47. Tariq M, Khan HA, al Moutaery K, and al Deeb S (1999) Protection by 2-deoxy-D-glucose against β,β′-iminodipropionitrile-induced neurobehavioral toxicity in mice. Exp Neurol 158:229-233.
48. Wagner GC, Ricaurte GA, Johanson CE, Schuster CR, and Seiden LS (1980) Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology 30:547-550.
49. Wan FJ, Lin HC, Kang BH, Tseng CJ, and Tung CS (1999) D-Amphetamine-induced depletion of energy and dopamine in the rat striatum is attenuated by nicotinamide pretreatment. Brain Res Bull 60:167-171.
50. Yuan J, Callahan BT, McCann UD, and Ricaurte GA (2001) Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity. J Neurochem 77:1338-1347.